{"id":"hypromellose-0-3","safety":{"commonSideEffects":[{"rate":null,"effect":"Blurred vision"},{"rate":null,"effect":"Eye irritation"},{"rate":null,"effect":"Mild stinging or burning"}]},"_chembl":{"chemblId":"CHEMBL2108956","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Hypromellose is a synthetic cellulose derivative that acts as an artificial tear substitute. When applied topically to the eye, it increases tear film viscosity and stability, providing lubrication and protection to the cornea and conjunctiva. This helps reduce friction and irritation associated with dry eye disease by maintaining moisture on the ocular surface.","oneSentence":"Hypromellose is a cellulose-based polymer that forms a protective lubricating film on the ocular surface to relieve dry eye symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:47:46.479Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye disease / Keratoconjunctivitis sicca"},{"name":"Ocular irritation and discomfort"}]},"trialDetails":[{"nctId":"NCT06089317","phase":"NA","title":"Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2024-07-28","conditions":"Dry Eye Syndromes","enrollment":200},{"nctId":"NCT05800353","phase":"NA","title":"Nd:YAG Laser Vitreolysis for Symptomatic Vitreous Floaters","status":"COMPLETED","sponsor":"Dongyang People's Hospital","startDate":"2022-11-22","conditions":"Weiss Ring","enrollment":70},{"nctId":"NCT06913387","phase":"NA","title":"Comparative Efficacy of Lipid Based Artificial Tears vs Aqueous Based Artificial Tears in Managing EDE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-20","conditions":"Evaporative Dry Eye","enrollment":60},{"nctId":"NCT04889209","phase":"PHASE1, PHASE2","title":"Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-05-28","conditions":"COVID-19","enrollment":867},{"nctId":"NCT06720428","phase":"NA","title":"Acupoint Therapy Device for Dry Eye","status":"COMPLETED","sponsor":"Shanghai 10th People's Hospital","startDate":"2021-01-01","conditions":"Dry Eye","enrollment":120},{"nctId":"NCT06190054","phase":"NA","title":"Evaluation of Performance and Safety of Eye Drops With Hydroxypropyl-methylcellulose and Inositol in Drye Eye Disease","status":"UNKNOWN","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2023-02-06","conditions":"Dry Eye Disease Associated to Asthenopia and Accommodative Effort in Video Display Terminal Users","enrollment":100},{"nctId":"NCT06209879","phase":"PHASE4","title":"Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT05292755","phase":"PHASE4","title":"Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-04-22","conditions":"Dry Eye Syndromes","enrollment":80},{"nctId":"NCT04541888","phase":"PHASE3","title":"Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease","status":"COMPLETED","sponsor":"Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.","startDate":"2020-11-05","conditions":"Dry Eye","enrollment":644},{"nctId":"NCT04970329","phase":"NA","title":"Corneal Thickness Changes in Patient Undergoing Dry Eye Managment","status":"UNKNOWN","sponsor":"University of Faisalabad","startDate":"2021-07","conditions":"Dry Eye Disease","enrollment":96},{"nctId":"NCT02382588","phase":"PHASE2","title":"Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2013-12-10","conditions":"Herpes Zoster Keratitis","enrollment":8},{"nctId":"NCT00748059","phase":"PHASE1","title":"The Pathophysiology of Orthostatic Hypotension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1996-12","conditions":"Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency","enrollment":10},{"nctId":"NCT04706455","phase":"NA","title":"Effect of Artificial Tears on the Parameters of the Eye and Its Impact on IOL Power Calculation for Cataract Surgery","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2020-12-01","conditions":"Cataract Senile, Dry Eye","enrollment":60},{"nctId":"NCT03084861","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy","status":"TERMINATED","sponsor":"Banc de Sang i Teixits","startDate":"2017-02-24","conditions":"Neurotrophic Keratopathy","enrollment":9},{"nctId":"NCT00909324","phase":"PHASE4","title":"Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-08-01","conditions":"Dry Eye","enrollment":170},{"nctId":"NCT03676335","phase":"PHASE2","title":"Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye","status":"COMPLETED","sponsor":"Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.","startDate":"2018-05-09","conditions":"Dry Eye","enrollment":240},{"nctId":"NCT03223909","phase":"PHASE4","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2016-10-13","conditions":"Dry Eye Syndrome","enrollment":326},{"nctId":"NCT03524157","phase":"PHASE1","title":"Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2017-07-17","conditions":"Dry Eye Syndromes, Lubricant Allergy, Tear Disorder","enrollment":30},{"nctId":"NCT04022811","phase":"PHASE4","title":"Effect of Bromfenac on Pain Related to Pterygium Surgery","status":"COMPLETED","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2016-10","conditions":"Pterygium, Pain","enrollment":60},{"nctId":"NCT03192826","phase":"PHASE4","title":"Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy","status":"COMPLETED","sponsor":"University Hospital of Patras","startDate":"2016-06-20","conditions":"Posterior Capsule Opacification, Ocular Hypertension","enrollment":79},{"nctId":"NCT03918590","phase":"PHASE4","title":"Post Intravitreal Injection Topical NSAID vs. Patching","status":"UNKNOWN","sponsor":"The New York Eye & Ear Infirmary","startDate":"2018-12-03","conditions":"Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion","enrollment":60},{"nctId":"NCT02417116","phase":"NA","title":"Tear Osmolarity Clinical Utility in Dry Eye Disease","status":"COMPLETED","sponsor":"Aston University","startDate":"2015-06","conditions":"Dry Eye","enrollment":120},{"nctId":"NCT03597867","phase":"PHASE3","title":"PGE2 Levels in Patient Treated With NSAIDs","status":"COMPLETED","sponsor":"University of Trieste","startDate":"2018-04-25","conditions":"Ocular Inflammation","enrollment":104},{"nctId":"NCT03406689","phase":"NA","title":"Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections","status":"COMPLETED","sponsor":"University Hospital of Patras","startDate":"2017-09-01","conditions":"Pain","enrollment":99},{"nctId":"NCT01533480","phase":"PHASE4","title":"A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis","status":"COMPLETED","sponsor":"Lifelong Vision Foundation","startDate":"2012-01","conditions":"Keratoconjunctivitis Due to Adenovirus, Viral Shedding","enrollment":20},{"nctId":"NCT01569191","phase":"PHASE4","title":"Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Aston University","startDate":"2012-03","conditions":"Hypersensitivity","enrollment":18},{"nctId":"NCT01657253","phase":"PHASE3","title":"Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2013-11","conditions":"Dry Eye","enrollment":183},{"nctId":"NCT03135509","phase":"PHASE1","title":"A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Celgene","startDate":"2017-05-24","conditions":"Healthy Volunteers","enrollment":16},{"nctId":"NCT02381288","phase":"PHASE2","title":"Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone","status":"TERMINATED","sponsor":"Takeda","startDate":"2015-09-10","conditions":"Low Testosterone","enrollment":17},{"nctId":"NCT02821390","phase":"NA","title":"Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections","status":"COMPLETED","sponsor":"University Hospital of Patras","startDate":"2016-06","conditions":"Pain","enrollment":55},{"nctId":"NCT02369796","phase":"PHASE2","title":"A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism","status":"TERMINATED","sponsor":"Takeda","startDate":"2015-02","conditions":"Hypogonadotropic Hypogonadism","enrollment":15},{"nctId":"NCT02897583","phase":"NA","title":"YAG Vitreolysis for Floaters","status":"COMPLETED","sponsor":"Ophthalmic Consultants of Boston","startDate":"2015-02","conditions":"Weiss Ring, Floaters, Posterior Vitreous Detachment","enrollment":52},{"nctId":"NCT01812044","phase":"NA","title":"Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery","status":"COMPLETED","sponsor":"Duke University","startDate":"2013-03","conditions":"Strabismus","enrollment":57},{"nctId":"NCT00598689","phase":"PHASE4","title":"GenTeal in Perioperative Treatment of Laser Assisted in Situ Keratomileusis LASIK Patients","status":"COMPLETED","sponsor":"Augusta University","startDate":"2007-10","conditions":"Corneal Epithelium Defect","enrollment":80},{"nctId":"NCT02097719","phase":"PHASE4","title":"Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-05","conditions":"Glaucoma, Ocular Hypertension","enrollment":100},{"nctId":"NCT01881126","phase":"PHASE4","title":"An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Allergan","startDate":"2013-06","conditions":"Glaucoma, Ocular Hypertension","enrollment":93},{"nctId":"NCT01732757","phase":"PHASE4","title":"A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2012-11","conditions":"Conjunctivitis, Allergic","enrollment":157},{"nctId":"NCT01791426","phase":"NA","title":"A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye","status":"WITHDRAWN","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-05","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT01470118","phase":"PHASE4","title":"A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-10","conditions":"Conjunctivitis, Allergic","enrollment":127},{"nctId":"NCT01282138","phase":"PHASE4","title":"Assessment of Alcon's Ocular Image Quantification System","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-12","conditions":"Allergic Conjunctivitis","enrollment":13},{"nctId":"NCT00681265","phase":"NA","title":"Tear Film Break-up Time After Instillation of Artificial Tears","status":"COMPLETED","sponsor":"Calm Water Therapeutics LLC","startDate":"2008-06","conditions":"Keratoconjunctivitis Sicca","enrollment":16},{"nctId":"NCT01600365","phase":"PHASE3","title":"Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus","status":"UNKNOWN","sponsor":"Adapt Produtos Oftalmológicos Ltda.","startDate":"2012-05","conditions":"Conjunctivitis, Adenovirus.","enrollment":22},{"nctId":"NCT01284439","phase":"NA","title":"Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2011-01","conditions":"Ocular Surface Disease, Glaucoma","enrollment":120},{"nctId":"NCT01075347","phase":"PHASE1","title":"Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2007-03","conditions":"Corneal Epithelial Defect, Diabetic Retinopathy, Penetrating Keratoplasty","enrollment":165}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["GenTeal®"],"phase":"marketed","status":"active","brandName":"hypromellose 0.3%","genericName":"hypromellose 0.3%","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hypromellose is a cellulose-based polymer that forms a protective lubricating film on the ocular surface to relieve dry eye symptoms. Used for Dry eye disease / Keratoconjunctivitis sicca, Ocular irritation and discomfort.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}